nitroglycerin has been researched along with pemetrexed in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hatachi, Y; Ito, I; Kim, YH; Masago, K; Mio, T; Mishima, M; Nagai, H; Sakamori, Y; Sasaki, T; Togashi, Y; Xue, D; Yamaya, M; Yasuda, H | 1 |
1 review(s) available for nitroglycerin and pemetrexed
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for nitroglycerin and pemetrexed
| Article | Year |
|---|---|
Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO‑cGMP signaling in lung adenocarcinoma cells in vitro and in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Nitric Oxide Donors; Nitroglycerin; Nitroso Compounds; Pemetrexed; Peptide Synthases; Replication Protein C; Second Messenger Systems; Tumor Burden | 2012 |